A Bioequivalence Study of Two Different PEG-rhGH Preparations

Clinical trial NCT06797505 · COMPLETED

Trial details

NCT number: NCT06797505
Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Pediatric Growth Hormone Deficiency (PGHD)

Start date: 2025-02-10
Primary completion: 2025-04-29
Enrollment: 87

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.